VOLABIOS

Partners

A collaborative effort for a common goal

The VOLABIOS project is powered by a multidisciplinary consortium of 18 partners and 2 affiliated organizations from 11 European countries. These partners bring together a wealth of expertise from academia, clinical research, technology, public health, and policymaking, ensuring a comprehensive and innovative approach to advancing schizophrenia diagnosis and monitoring.

Project Partners

Israel Institute of Technology universidade de coimbra hhu_logo.max 225x110 1 smartnanosense innovation logo_998802502 ainigma-logo.max-225x110 Ministry of Health Greece logo.max 225x110 1 TIMELEX logo.max 225x110 1 cubic_snail_logo.max 225x110 1 University of Cambridge technion_rnd_ltd.max 225x110 1 ZSI – Centre for Social Innovation BETT logo exus_ai_labs_logo.max 225x110 1 HUVM_logo.max 225x110 1 junta de andalucia fisevi_logo.max 225x110 1 logo-uniklinik-rwth-aachen.max-225x110 lithuanian university Firalis

Our consortium includes:

Academic and Research Institutions

Leading universities and research centers conducting groundbreaking studies on mental health and diagnostics.

Clinical Centers

Hospitals and healthcare organizations at the forefront of patient care and clinical trials.

Technology Developers

Experts in artificial intelligence, mobile spectrometry, and data analysis driving innovation.

Public Health Organizations

Policymakers and health authorities aligning the project with public health priorities.

54
Months Duration
18 +
Partners
8 €
Millions Funding
3500 +
Patients in Clinical Research
6
Academic & Research Partners
6
Medical Science Partners
6
Industrial Partners & SMEs
1
Policy Makers

How Our Collaboration Works

The success of VOLABIOS relies on close collaboration among its partners, each contributing their unique strengths:

  • Data Sharing: Collaborative use of multi-omics data and clinical insights.
  • Interdisciplinary Research: Integration of expertise across various scientific fields.
  • Strategic Guidance: Input from an advisory board of internationally recognized experts in psychiatry, neuroscience, and public health.

Why collaboration matters

The scale and complexity of schizophrenia diagnosis require a global effort. By uniting diverse perspectives and expertise, VOLABIOS ensures:

  • Rigorous scientific standards.
  • Sustainable and impactful solutions for mental health diagnostics.
  • Broad applicability of its findings across healthcare systems.